Glaukos (GKOS) Common Equity (2014 - 2026)
Glaukos' (GKOS) quarterly Common Equity came in at $670.9 million in Q1 2026, down 12.18% year-on-year from $764.0 million in Q1 2025, and up 2.25% on a QoQ basis from $656.2 million in Q4 2025.
Glaukos (GKOS) Common Equity (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Common Equity data on file, last reported at $670.9 million in Q1 2026.
- On a quarterly basis, Common Equity fell 12.18% year-over-year to $670.9 million in Q1 2026; TTM through Mar 2026 was $670.9 million, a 12.18% decrease from a year earlier, with the FY2025 full-year figure at $656.2 million, down 14.44% from the prior year.
- Common Equity for Q1 2026 stood at $670.9 million, up from $656.2 million in the prior quarter.
- Over the last five years, Common Equity for GKOS reached as high as $769.5 million in Q3 2025 and fell as low as $450.7 million in Q1 2024.
- Historically, Common Equity has averaged $609.0 million across 5 years, with a median of $597.6 million in 2022.
- Across the five-year window, Common Equity decreased 14.9% in 2023 and soared 69.49% in 2025, its largest moves.
- Year by year, Common Equity stood at $530.0 million in 2022, then retreated by 12.88% to $461.8 million in 2023, then soared by 66.09% to $766.9 million in 2024, then retreated by 14.44% to $656.2 million in 2025, then gained by 2.25% to $670.9 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $670.9 million in Q1 2026, $656.2 million in Q4 2025, and $769.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 670.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 670.93 Mn |
| Dec 31, 2025 | 656.16 Mn |
| Sep 30, 2025 | 769.54 Mn |
| Jun 30, 2025 | 765.11 Mn |
| Mar 31, 2025 | 763.96 Mn |
| Dec 31, 2024 | 766.93 Mn |
| Sep 30, 2024 | 668.51 Mn |
| Jun 30, 2024 | 665.16 Mn |
| Mar 31, 2024 | 450.73 Mn |
| Dec 31, 2023 | 461.77 Mn |
| Sep 30, 2023 | 477.66 Mn |
| Jun 30, 2023 | 488.81 Mn |
| Mar 31, 2023 | 508.51 Mn |
| Dec 31, 2022 | 530.01 Mn |
| Sep 30, 2022 | 548.55 Mn |
| Jun 30, 2022 | 562.48 Mn |
| Mar 31, 2022 | 597.56 Mn |
| Dec 31, 2021 | 587.15 Mn |
| Sep 30, 2021 | 601.05 Mn |
| Jun 30, 2021 | 584.33 Mn |